Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for May 17th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 17th:

The Timken Company (TKR - Free Report) : This engineered bearings and power transmission products manufacturer has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 9.8% over the last 60 days.

Timken has a price-to-earnings ratio (P/E) of 9.07, compared with 10.70 for the industry. The company possesses a Value Score of B.

Reliance Steel & Aluminum Co. (RS - Free Report) : This metals service center company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.1% over the last 60 days.

Reliance Steel & Aluminum has a price-to-earnings ratio (P/E) of 9.79, compared with 17.80 for the industry. The company possesses a Value Score of A.

Office Properties Income Trust (OPI - Free Report) : This owner and leaser of buildings has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 3.7% over the last 60 days.

Office Properties Income Trust has a price-to-earnings ratio (P/E) of 5.09, compared with 19.20 for the industry. The company possesses a Value Score of B.

Victory Capital Holdings, Inc. (VCTR - Free Report) : This independent investment management company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.7% over the last 60 days.

Victory Capital has a price-to-earnings ratio (P/E) of 7.18 compared with 62.20 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



More from Zacks Zacks #1 Rank Additions

You May Like

Published in